The largest database of trusted experimental protocols

Live h1n1 attenuated influenza a pr8 iav

Manufactured by Charles River Laboratories

The Live H1N1 attenuated influenza A/PR8 (IAV) is a laboratory-prepared influenza virus strain. It serves as a core component for research and development purposes.

Automatically generated - may contain errors

2 protocols using live h1n1 attenuated influenza a pr8 iav

1

Whole Blood Stimulation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
TruCulture whole blood stimulations were performed as previously described.15 (link) Briefly, tubes were prepared in batch with the indicated stimulus, resuspended in a volume of 2 mL buffered media, and maintained at −20°C until time of use. Stimuli in this study included lipopolysaccharide (LPS, 10 ng/mL) derived from E. coli O111:B4 (Invivogen), vaccine-grade poly I:C (pIC, 20 μg/mL) (Invivogen), live Bacillus Calmette-Guerin (Immucyst, Sanofi Pasteur), live H1N1 attenuated influenza A/PR8 (IAV, 100 HAU) (Charles River), a superantigen Enterotoxin (SEB, 0.4 μg/mL) (Bernhard Nocht Institute), and a Null control. 1 mL of whole blood was distributed into each of the prewarmed TruCulture tubes, inserted into a dry block incubator, and maintained at 37°C room air for 22 h. At the end of the incubation period, tubes were opened and a valve was inserted in order to separate the sedimented cells from the supernatant and to stop the stimulation reaction. Liquid supernatants were aliquoted (for paired oxylipin and cytokine analysis) and immediately frozen at 80°C until the time of use.
+ Open protocol
+ Expand
2

Standardized TruCulture Whole-Blood Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
TruCulture whole-blood stimulations were performed in a standardized way as previously described4 (link),43 (link). Briefly, tubes were prepared in batch with the indicated stimulus, resuspended in a volume of 2 ml buffered medium, and maintained at −20 °C until time of use. Stimuli used in this study were LPS derived from E. coli O111:B4 (Invivogen), E. coli O111:B4 (Invivogen), C. albicans (Invivogen), vaccine-grade poly I:C (Invivogen), live Bacillus Calmette-Guerin (Immucyst, Sanofi Pasteur), live H1N1 attenuated influenza A/PR8 (IAV) (Charles River), SEB (Bernhard Nocht Institute), CD3 + CD28 (R&D Systems and Beckman Coulter), and cytokines TNF (Miltenyi Biotech), IL-1β (Peprotech) and IFNγ (Boehringer Ingelheim). One millilitre of whole blood was distributed into each of the prewarmed TruCulture tubes, inserted into a dry block incubator, and maintained at 37 °C room air for 22 h. At the end of the incubation period, tubes were opened, and a valve was inserted in order to separate the sedimented cells from the supernatant and to stop the stimulation reaction. Liquid supernatants were aliquoted and immediately frozen at −80 °C until the time of use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!